To explore the molecular and immunological basis of glomerular diseases, tubular transport disorders, vascular calcification, kidney replacement therapy and ciliopathies.
To develop biomarkers for optimal prediction of disease prognosis and treatment efficacy.
To study therapeutic strategies that emerge from these insights.
We aim to have a major impact on the future of clinical care for patients with kidney disease and to be at the forefront of the international field of nephrology research.